Anti-CP2W1/ CYP2W1 monoclonal antibody

Anti-CP2W1/ CYP2W1 antibody for FACS & in-vivo assay

Target products collectionGo to CYP2W1/CYP2W1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2576-Ab-1/ GM-Tg-hg-MP2576-Ab-2Anti-Human CYP2W1 monoclonal antibodyHuman
GM-Tg-rg-MP2576-Ab-1/ GM-Tg-rg-MP2576-Ab-2Anti-Rat CYP2W1 monoclonal antibodyRat
GM-Tg-mg-MP2576-Ab-1/ GM-Tg-mg-MP2576-Ab-2Anti-Mouse CYP2W1 monoclonal antibodyMouse
GM-Tg-cynog-MP2576-Ab-1/ GM-Tg-cynog-MP2576-Ab-2Anti-Cynomolgus/ Rhesus macaque CYP2W1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2576-Ab-1/ GM-Tg-felg-MP2576-Ab-2Anti-Feline CYP2W1 monoclonal antibodyFeline
GM-Tg-cang-MP2576-Ab-1/ GM-Tg-cang-MP2576-Ab-2Anti-Canine CYP2W1 monoclonal antibodyCanine
GM-Tg-bovg-MP2576-Ab-1/ GM-Tg-bovg-MP2576-Ab-2Anti-Bovine CYP2W1 monoclonal antibodyBovine
GM-Tg-equg-MP2576-Ab-1/ GM-Tg-equg-MP2576-Ab-2Anti-Equine CYP2W1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2576-Ab-1/ GM-Tg-hg-MP2576-Ab-2; GM-Tg-rg-MP2576-Ab-1/ GM-Tg-rg-MP2576-Ab-2;
GM-Tg-mg-MP2576-Ab-1/ GM-Tg-mg-MP2576-Ab-2; GM-Tg-cynog-MP2576-Ab-1/ GM-Tg-cynog-MP2576-Ab-2;
GM-Tg-felg-MP2576-Ab-1/ GM-Tg-felg-MP2576-Ab-2; GM-Tg-cang-MP2576-Ab-1/ GM-Tg-cang-MP2576-Ab-2;
GM-Tg-bovg-MP2576-Ab-1/ GM-Tg-bovg-MP2576-Ab-2; GM-Tg-equg-MP2576-Ab-1/ GM-Tg-equg-MP2576-Ab-2
Products NameAnti-CYP2W1 monoclonal antibody
Formatmab
Target NameCYP2W1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CYP2W1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CP2W1/ CYP2W1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000102human CYP2W1 Lentivirus particle
    ORF Viral VectorpGMLV000102human CYP2W1 Lentivirus plasmid


    Target information

    Target IDGM-MP2576
    Target NameCYP2W1
    Gene ID54905,545817,288517,709073,491601,101088802,618939,100053875
    Gene Symbol and SynonymsCYP2W1,Gm455
    Uniprot AccessionQ8TAV3
    Uniprot Entry NameCP2W1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000073067
    Target ClassificationN/A

    The target: CYP2W1, gene name: CYP2W1, also named as . This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.